Inactive Instrument

Highlights Sierra Oncology, Inc.

Equities

SRRA

US82640U4040

Highlights

Unlock all the news: Be the first to know and act before the market!

Sierra Oncology, Inc. Announces Update on Sra737	23-03-06	CI
Sareum Holdings Says GSK Completes Acquisition of Sierra Oncology	22-07-04	DJ
Sierra Oncology, Inc. Announces Executive Changes	22-07-01	CI
GSK Completes $1.9 Billion Purchase of Sierra Oncology	22-07-01	MT
GlaxoSmithKline plc completed the acquisition of Sierra Oncology, Inc. from Frazier Healthcare VI, L.P., Frazier Life Sciences VIII, L.P., Frazier Life Sciences Public Fund, L.P., all managed by Frazier Management, L.L.C., and others.	22-06-30	CI
Sierra Oncology Shareholders Approve Acquisition by GSK	22-06-29	MT
Sierra Oncology, Inc. Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration	22-06-17	CI
Pfizer to sell stake in GSK's consumer health business after it lists	22-06-01	RE
GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster	22-05-31	RE
Sierra Oncology, Inc. Announces Momelotinib Pivotal Phase 3 Data Receives Oral Presentation At American Society of Clinical Oncology Annual Meeting	22-05-26	CI
Sierra Oncology's Q1 Net Loss Narrows	22-05-06	MT
Sierra Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
Earnings Flash (SRRA) SIERRA ONCOLOGY Reports Q1 Loss $-1.33	22-05-06	MT
GSK tops forecasts as consumer health spin-off nears	22-04-27	RE
GlaxoSmithKline to Acquire Sierra Oncology for $1.9 Billion -- Shares Surge Amid Heavy Trading Volume	22-04-13	MT
Sareum Shares Jump 9% on Ties to GSK's Takeover Target Sierra Oncology	22-04-13	MT
GlaxoSmithKline to Acquire Sierra Oncology for $1.9 Billion	22-04-13	MT
GSK to buy Sierra Oncology amid pressure to boost drug pipeline	22-04-13	RE
North American Morning Briefing: Stock Futures Tick Up Ahead of Earnings	22-04-13	DJ
FTSE 100 Rises as Sterling Falls After Inflation Data	22-04-13	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sierra Oncology, Inc.

Equities

SRRA

US82640U4040

Highlights

Filters